Mechanism‐Based Enterohepatic Circulation Model of Mycophenolic Acid and Its Glucuronide Metabolite: Assessment of Impact of Cyclosporine Dose in Asian Renal Transplant Patients

Authors:
  • AVAnantharaman Vathsala
    Anantharaman Vathsala
  • HLHuei‐Xin Lou
    Huei‐Xin Lou
  • SZShufeng Zhou
    Shufeng Zhou
  • ECEli Chan
    Eli Chan
Publisher website
Google Scholar
Abstract
Mycophenolic acid (MPA) is mainly metabolized to MPA‐glucuronide (MPAG), which may be reconverted to MPA following enterohepatic circulation (EHC). A physiologically realistic EHC model was proposed to estimate and assess the impact of cyclosporine (CsA) dose on the extent of EHC of MPA and MPAG. After the first oral dose of mycophenolate mofetil (MMF), the MPA and MPAG plasma concentration‐time data of 14 adult renal transplant patients (12 receiving concomitant CsA and prednisolone and 2 receiving only concomitant prednisolone without CsA) were analyzed by individual pharmacokinetic modeling using a proposed 5‐compartment drug and metabolite EHC model with a time‐varying gallbladder emptying process. Simulations were performed to assess the influence of the time of bile release after dosing (Tbile) and the gallbladder emptying interval (τgall) on the EHC process. The extent of EHC for both MPA and MPAG tended to be lower in the group receiving CsA coadministration and decreased with increasing total body weight—adjusted CsA dose. Simulations revealed that Tbile and τgall influenced the time of occurrence and maximum concentration of the second peak, as well as the extent of EHC, for MPA and MPAG.

This publication has 25 references indexed in Scilit: